Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5079601
Max Phase: Preclinical
Molecular Formula: C21H28F3N7O
Molecular Weight: 451.50
Molecule Type: Unknown
Associated Items:
ID: ALA5079601
Max Phase: Preclinical
Molecular Formula: C21H28F3N7O
Molecular Weight: 451.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1nn(CC(F)(F)F)cc1Nc1ncc(C2CC2)c(NCCCNC(=O)C2CCC2)n1
Standard InChI: InChI=1S/C21H28F3N7O/c1-13-17(11-31(30-13)12-21(22,23)24)28-20-27-10-16(14-6-7-14)18(29-20)25-8-3-9-26-19(32)15-4-2-5-15/h10-11,14-15H,2-9,12H2,1H3,(H,26,32)(H2,25,27,28,29)
Standard InChI Key: MHPBLCYPFBBOND-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 451.50 | Molecular Weight (Monoisotopic): 451.2307 | AlogP: 3.88 | #Rotatable Bonds: 10 |
Polar Surface Area: 96.76 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.65 | CX Basic pKa: 4.32 | CX LogP: 2.84 | CX LogD: 2.84 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.47 | Np Likeness Score: -1.58 |
1. Drewry DH, Annor-Gyamfi JK, Wells CI, Pickett JE, Dederer V, Preuss F, Mathea S, Axtman AD.. (2022) Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration., 65 (2.0): [PMID:34333981] [10.1021/acs.jmedchem.1c00440] |
Source(1):